Doctors Note Logo

Published on: 5/5/2026

Is Platelet-Rich Plasma FDA Approved? (Current Regulations)

PRP itself is not FDA approved as a drug or biologic for therapeutic use; instead, the centrifuges, tubes and kits used to prepare it are regulated as medical devices and often 510(k)-cleared for safety and performance. Clinicians may use the resulting plasma off-label across orthopedics, sports medicine, dermatology and hair restoration, so outcomes and risks vary based on device protocols and patient factors.

There are several important details about device quality, off-label applications, safety considerations and realistic expectations to weigh. See below for more information to guide your healthcare decisions.

answer background

Explanation

Is Platelet-Rich Plasma FDA Approved? (Current Regulations)

Platelet-Rich Plasma (PRP) has gained popularity in fields ranging from orthopedics and sports medicine to dermatology and hair restoration. If you're considering PRP, you may wonder about "FDA approval for PRP" and what that means for safety, effectiveness and regulation. Below is a clear overview of PRP, how it's regulated by the U.S. Food and Drug Administration (FDA), and what you should know before pursuing treatment.

What Is Platelet-Rich Plasma (PRP)?

PRP is a concentration of platelets derived from a patient's own blood. It's thought to speed healing by delivering growth factors directly to the treatment site.

Key points about PRP:

  • It's autologous, meaning it uses your own blood.
  • Platelets are spun down in a centrifuge to increase concentration.
  • It's injected or applied topically to target areas (joints, tendons, scalp, skin).
  • Popular uses include tendon or ligament injuries, osteoarthritis, hair loss, and skin rejuvenation.

Understanding FDA Regulation

The FDA evaluates medical products under different categories: biologics (like vaccines), drugs, and medical devices. PRP sits at the intersection:

  1. PRP Itself as a Biologic

    • PRP is made from your own blood.
    • Under FDA rules, minimally manipulated autologous products for homologous use (i.e., used in the same basic function or location) generally do not require pre-market approval as a drug or biologic.
    • The FDA's 2017 "Same Surgical Procedure Exception" clarifies that blood components used in the same procedure for the same patient are exempt from biologics licensing, provided they're not combined with other agents.
  2. Devices and Kits to Prepare PRP

    • The centrifuges, collection tubes and related devices used to produce PRP are regulated as medical devices.
    • Many PRP systems have received FDA 510(k) clearance, meaning the manufacturer demonstrated that the device is substantially equivalent to a legally marketed device.
    • FDA clearance does not mean the agency evaluated the efficacy of PRP for every indication; it simply reviews device safety and performance.

"FDA Approval for PRP" vs. "FDA-Cleared PRP Systems"

  • There is no specific FDA approval for PRP as a drug or biologic therapy across all uses.
  • The focus is on the devices that separate and concentrate platelets. These devices:
    • Must meet quality and safety standards.
    • Are cleared under 510(k) or, less commonly, approved under the more stringent Premarket Approval (PMA) pathway if they differ significantly from existing products.

Examples of FDA-Cleared PRP Systems

(for illustration; check the most current FDA database for updates)

  • Devices using single-spin or dual-spin centrifugation processes.
  • Closed, sterile collection systems designed to minimize contamination.
  • Systems that report average platelet recovery rates in labeling.

Clinical Use and Off-Label Applications

Once a PRP device is cleared, clinicians may use the resulting PRP for various "off-label" purposes. Common applications include:

  • Orthopedics: Tendon injuries, muscle strains, osteoarthritis
  • Sports Medicine: Acute ligament sprains, muscle tears
  • Dermatology & Aesthetics: Skin rejuvenation, scar treatment
  • Hair Restoration: Androgenetic alopecia and other hair loss conditions

Note: Off-label use is legal and common in medicine but places responsibility on the provider to discuss risks, benefits and alternatives with you.

Safety and Quality Considerations

Because PRP comes from your own blood, the risk of allergic reaction or disease transmission is low. However, certain factors warrant careful evaluation:

  • Technique Variation: Different devices and protocols yield different platelet concentrations and growth-factor levels.
  • Sterility: Ensure the clinic follows strict sterile protocols to avoid infection.
  • Patient Factors: Underlying health issues (e.g., bleeding disorders, infections) may affect safety or outcomes.
  • Expected Outcomes: Not all conditions respond the same way—some studies show mixed results for certain tendon injuries or arthritis.

What the Research Says

  • Positive Findings: Some randomized trials and meta-analyses support PRP for knee osteoarthritis pain relief and certain tendon injuries.
  • Mixed Evidence: Other studies show limited or no significant benefits for some indications (e.g., chronic plantar fasciitis).
  • Ongoing Trials: Research is active in areas like sports injuries, hair loss and skin rejuvenation.

Always discuss published evidence and expected outcomes with your treating physician.

Key Takeaways on "FDA Approval for PRP"

  • PRP itself is not FDA-approved as a standalone drug or biologic for all uses.
  • The devices that prepare PRP are often FDA-cleared under 510(k) pathways, meaning they meet safety and performance standards.
  • Clinicians may use PRP off-label; you should have a frank discussion about risks, benefits and alternatives.
  • No regulatory pathway currently requires pre-market approval of the PRP product itself when used in a same-day procedure for the same patient.

Before You Proceed

  1. Verify that the clinic uses an FDA-cleared PRP system.
  2. Ask about the specific protocol: centrifugation steps, platelet counts achieved, use of activating agents.
  3. Request details on potential risks: infection control, site-specific complications.
  4. Discuss realistic expectations: how many sessions, timeline for improvement and possible need for adjunctive therapies.

If you're experiencing pain, hair loss or skin issues and want to better understand your symptoms before weighing PRP therapy, try Ubie's free Medically approved LLM Symptom Checker Chat Bot to get personalized insights and help determine your next steps.

When to Speak to a Doctor

PRP is generally safe but may not be suitable for everyone—especially if you have conditions like active infections, blood disorders or certain cancers. Always:

  • Disclose your full medical history and medications.
  • Discuss any red-flag symptoms (sudden swelling, severe pain, neurological deficits) immediately.
  • Seek emergency care if you have signs of a serious reaction or life-threatening condition.

This overview provides a foundation for understanding "FDA approval for PRP" and current U.S. regulations. To make informed decisions about your health, speak to a qualified physician who can tailor recommendations to your specific situation.

(References)

  • * Malekpour Z, Ghasem S, Dhotekar K, Dhotekar H, Miller AO, Hocker JT, Malekpour M, Puskas P, Ranson E. Platelet-Rich Plasma and the FDA: A Review of the Current Regulatory Framework and Impact on Clinical Practice. J Orthop Sports Phys Ther. 2024 Jan;54(1):21-27. doi: 10.2519/jospt.2024.11894. Epub 2023 Nov 21. PMID: 37989914.

  • * Sánchez M, Delgado D, Pombo J, Anitua E. Platelet-rich plasma: a narrative review of regulatory guidelines and practical applications in orthopedics. Front Surg. 2023 Jul 21;10:1198662. doi: 10.3389/fsurg.2023.1198662. PMID: 37546376; PMCID: PMC10400030.

  • * Cook CS, Smith SL, Cook CC, Smith J. US FDA regulation of platelet-rich plasma for musculoskeletal indications: a review. J Bone Joint Surg Am. 2021 Mar 17;103(6):531-537. doi: 10.2106/JBJS.20.00947. PMID: 33729900.

  • * Mautner K, Malanga G, Smith J, Cook C. The regulation of platelet-rich plasma (PRP) in the United States. Clin Sports Med. 2020 Jan;39(1):15-26. doi: 10.1016/j.csm.2019.08.006. Epub 2019 Oct 12. PMID: 31761047.

  • * Lau V, Shah S, Cvetanovich GL, Lin J. Regulatory considerations for autologous platelet-rich plasma. Transfusion. 2019 Jun;59(6):1885-1891. doi: 10.1111/trf.15286. Epub 2019 Mar 26. PMID: 30912165.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.